Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination

Clinical trial NCT01772836 · COMPLETED

Trial details

NCT number: NCT01772836
Sponsor: Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Bacterial Infections

Start date: 2013-03-01
Primary completion: 2013-03-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.